Physician profile
A Jay Staub
NPI 1578565222
$14,687.87
in general payments reported to CMS, 2019-2025
37 companies · $278 in 2025
The $278 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $582 · 2020: $207 · 2021: $217 · 2022: $2,103 · 2023: $7,953 · 2024: $3,347 · 2025: $278.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,000 · Honoraria: $2,500 · Consulting Fee: $1,500 · Food and Beverage: $1,463 · Education: $99.99 · Gift: $15.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,000.00 |
| Honoraria | $2,500.00 |
| Consulting Fee | $1,500.00 |
| Food and Beverage | $1,462.72 |
| Education | $99.99 |
| Gift | $15.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ascend Therapeutics US, LLC | $11,842.21 | 2022-2024 | |
| Astellas Pharma US INC | $437.48 | 2019-2025 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $273.93 | 2019-2025 | Slynd |
| Abbvie INC. | $260.09 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Merck Sharp & Dohme LLC | $224.31 | 2019-2024 | Gardasil, Gardasil 9 |
| Pfizer INC. | $172.89 | 2019-2024 | |
| Organon LLC | $148.02 | 2021-2025 | Nexplanon |
| Gynesonics, INC. | $135.69 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Mayne Pharma Commercial LLC | $129.23 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $127.67 | 2019-2025 | |
| Amgen INC. | $92.07 | 2019-2025 | Evenity |
| Millicent US INC | $82.91 | 2022-2024 | Femring, Intrarosa |
| Therapeuticsmd, INC. | $75.83 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $65.34 | 2023-2024 | Myfembree |
| Shield Therapeutics INC | $63.95 | 2023-2025 | Accrufer |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $60.42 | 2023-2025 | Cologuard Collection Kit |
| Aspira Women'S Health INC | $55.66 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $52.36 | 2019-2020 | |
| Vertical Pharmaceuticals, LLC | $40.68 | 2020 | |
| Integra Lifesciences Corporation | $34.61 | 2023-2025 | Codman Hakim, Cusa Clarity, Duraseal Exact Spinal Sealant System |
| Channel Medsystems, INC. | $33.05 | 2023 | |
| Ethicon US, LLC | $28.38 | 2019-2023 | |
| Duchesnay USA Incorporated | $25.12 | 2019 | |
| Innovation Technologies INC | $24.37 | 2023 | Irrisept |
| Agile Therapeutics, INC. | $24.25 | 2021 | |
| Minerva Surgical, INC | $22.80 | 2022 | |
| Hologic Sales and Service, LLC | $20.22 | 2025 | Novasure, Omni Hysteroscope, Myosure Tissue Removal Device |
| Medtronic, INC. | $19.42 | 2023 | V-Loc 180 |
| Olympus America INC. | $18.50 | 2023 | Olympus, 4k Cable 8.5m |
| Evofem Biosciences, INC. | $16.24 | 2021 | |
| Coopersurgical, INC. | $15.50 | 2025 | |
| Avion Pharmaceuticals | $13.84 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $13.31 | 2020 | |
| Caldera Medical, INC | $13.14 | 2021 | |
| Meditrina | $12.20 | 2022 | |
| Convatec INC. | $12.18 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw A Staub listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.